Medicare Enrolled

Dr. Sreenivas Chittoor, M.D.

Hematology & Oncology · Mesquite, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
4700 N GALLOWAY AVE, Mesquite, TX 75150
9726866411
In practice since 2006 (19 years)
NPI: 1407894439 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chittoor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chittoor? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chittoor

Dr. Sreenivas Chittoor is a hematology & oncology in Mesquite, TX, with 19 years in practice. Based on federal Medicare data, Dr. Chittoor performed 6,487 Medicare services across 1,463 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chittoor received a total of $31,235 from 40 pharmaceutical and/or device companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chittoor is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 38% volume in TX$ $31,235 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,487
Medicare services
Top 38% in TX for hematology & oncology
1,463
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~341 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging (iodine-based)2,830$0$3
Complete blood count (CBC) with differential622$8$36
Blood draw (venipuncture)621$8$20
Comprehensive metabolic blood panel549$10$64
Lactate dehydrogenase (enzyme) level500$6$31
Office visit, established patient (30-39 min)406$92$368
Ferritin level test (iron stores)123$13$60
Iron level test123$6$27
Iron binding capacity test123$8$35
Office visit, established patient (20-29 min)95$55$250
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session74$291$2,762
Reticulated (young) platelet measurement56$35$143
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev50$190$700
Drug injection, under skin or into muscle47$11$96
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries39$89$657
Nuclear medicine study from skull base to mid-thigh with ct scan37$1,147$4,802
Microscopic examination for white blood cells with manual cell count30$4$22
Complete blood count (CBC), automated30$6$34
Injection of drug or substance into vein29$27$247
Ct scan of chest with contrast27$52$821
CT scan of abdomen and pelvis with contrast21$182$1,067
Administration of chemotherapy into vein, 1 hour or less21$93$707
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less19$46$313
New patient office visit, complex (60-74 min)15$160$709
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
47.2% medium
52.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$31,235
Total received (2018-2024)
Avg $5,206/year across 6 years
Top 15% in TX for hematology & oncology
40
Companies
102
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,361 (52.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13,236 (42.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,637 (5.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,356
2023
$7,403
2022
$2,475
2021
$1,897
2019
$3,800
2018
$7,304

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$7,290
Exelixis Inc.
$5,100
ROCHE MOLECULAR SYSTEMS, INC.
$3,751
Ipsen Biopharmaceuticals, Inc
$2,944
BeiGene USA, Inc.
$2,590
Gilead Sciences, Inc.
$1,736
Daiichi Sankyo Inc.
$1,415
Janssen Biotech, Inc.
$1,368
Karyopharm Therapeutics Inc.
$1,100
Adaptive Biotechnologies Corporation
$800
G1 Therapeutics, Inc.
$509
Incyte Corporation
$435
GENZYME CORPORATION
$358
COMSORT, Inc
$250
ADC Therapeutics America, Inc.
$194
Bayer HealthCare Pharmaceuticals Inc.
$150
Myriad Genetic Laboratories, Inc.
$136
Roche Diagnostics Corporation
$136
Lilly USA, LLC
$117
SERVIER PHARMACEUTICALS LLC
$114
SOBI, INC
$83
Novartis Pharmaceuticals Corporation
$72
Sirtex Medical Inc
$61
Pharmacyclics LLC, An AbbVie Company
$52
ABBVIE INC.
$51
Genentech USA, Inc.
$46
Kite Pharma, Inc.
$45
PFIZER INC.
$42
Tempus AI, Inc
$39
Sun Pharmaceutical Industries Inc.
$38
E.R. Squibb & Sons, L.L.C.
$30
Foundation Medicine, Inc.
$28
Sumitomo Pharma America, Inc.
$27
Myovant Sciences Inc.
$24
MorphoSys, US Inc.
$20
Medtronic USA, Inc.
$18
GE HealthCare
$17
AbbVie Inc.
$16
Stemline Therapeutics Inc.
$15
Epizyme, Inc.,
$15
Top 3 companies account for 51.7% of total payments
Associated products mentioned in payments ›
BRUKINSA · CALQUENCE · COSELA · Cabometyx · Doptelet · ENHERTU · EPKINLY · ERLEADA · IMBRUVICA · IMFINZI · JEVTANA · KEYTRUDA · KISQALI · LUTATHERA · MONJUVI · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION · OXBRYTA · Odomzo · Orserdu · PADCEV · PLUVICTO · PRECISETUMOR · Perjeta · SIR-Spheres Microspheres · SOMATULINE DEPOT · TAGRISSO · TAZVERIK · TECENTRIQ · Tazverik · VENCLEXTA · VERZENIO · VONJO · Vitrakvi · XPOVIO · XTANDI · YONSA · Yescarta · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (52%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $481 per 100 Medicare services performed
Looking for a hematology & oncology in Mesquite?
Compare hematology & oncologys in the Mesquite area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
115
Per 100K population
4.4
County median income
$74,149
Nearest hospital
DALLAS REGIONAL MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chittoor is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 15%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Chittoor experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Chittoor performed 2,830 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chittoor receive payments from pharmaceutical companies?
Yes. Dr. Chittoor received a total of $31,235 from 40 companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chittoor's costs compare to other hematology & oncologys in Mesquite?
Dr. Chittoor's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chittoor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →